Scpharmaceuticals Is A Pharmaceutical Company Based In Burlingtonmassachusettsfounded In 2013The Company Focuses On Developing And Commercializing Innovative Therapies In The Cardiorenal Spaceaiming To Enhance Patient Outcomes And Quality Of Lifetheir Mission Is To Advance Healthcare For Patients With Heart Failure And Chronic Kidney Disease Through Integrated Treatments That Address Unmet Needs One Of Their Key Products Is Furoscixa Furosemide Injection That Received Fda Approval In 2022 For Heart Failure And Expanded Its Indication To Chronic Kidney Disease In 2025The Company Is Also Developing The Scp 111 Autoinjector To Improve Patient Care Through Drug Device Combinationsscpharmaceuticals Is Dedicated To Pharmaceutical Developmentproduct Commercializationand Creating Solutions That Combine Drugs With Devices To Improve Treatment Outcomes For Patients And Healthcare Providers
